Your browser doesn't support javascript.
loading
Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J).
Watanabe, Yasuhiro; Beeldman, Emma; Raaphorst, Joost; Izumi, Yuishin; Yoshino, Hiide; Masuda, Michihito; Atsuta, Naoki; Ito, Satoru; Adachi, Tadashi; Adachi, Yoshiki; Yokota, Osamu; Oda, Masaya; Hanashima, Ritsuko; Ogino, Mieko; Ichikawa, Hiroo; Hasegawa, Kazuko; Kimura, Hideki; Shimizu, Toshio; Aiba, Ikuko; Yabe, Hayato; Kanba, Makoto; Kusumi, Kimiyoshi; Aoki, Tetsuya; Hiroe, Yu; Watanabe, Hirohisa; Nishiyama, Kazutoshi; Nomoto, Masahiro; Sobue, Gen; Nakashima, Kenji.
Afiliação
  • Watanabe Y; Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan. Electronic address: yawatana@med.tottori-u.ac.jp.
  • Beeldman E; Department of Neurology, Academic Medical Centre, Amsterdam, The Netherlands.
  • Raaphorst J; Department of Neurology, Radboud UMC, Nijmegen, The Netherlands.
  • Izumi Y; Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
  • Yoshino H; Yoshino Neurology Clinic, Ichikawa, Japan.
  • Masuda M; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Atsuta N; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ito S; Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.
  • Adachi T; Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.
  • Adachi Y; Department of Neurology, National Hospital Organization, Matsue Medical Center, Matsue, Japan.
  • Yokota O; Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Oda M; Department of Neurology, Vihara Hananosato Hospital, Miyoshi, Japan.
  • Hanashima R; Department of Neurology, Kitasato University School of Medicine, Kanagawa, Japan.
  • Ogino M; Kitasato University, Department of Comprehensive Medicine, Division of Integrated Care and Whole Person Care, Kanagawa, Japan.
  • Ichikawa H; Department of Neurology, Showa University Fujigaoka Hospital, Kanagawa, Japan.
  • Hasegawa K; National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.
  • Kimura H; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
  • Shimizu T; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
  • Aiba I; Department of Neurology, National Hospital Organization, Higashi Nagoya National Hospital, Nagoya, Japan.
  • Yabe H; Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Kanba M; Yodoe Clinic, Yonago, Japan.
  • Kusumi K; Department of Neurology, San-in Rosai Hospital, Yonago, Japan.
  • Aoki T; Akasaki Medical Office, Kotoura, Japan.
  • Hiroe Y; Division of Neuropsychiatry, Yowa Hospital, Yonago, Japan.
  • Watanabe H; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Nishiyama K; Department of Neurology, Kitasato University School of Medicine, Kanagawa, Japan.
  • Nomoto M; Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Sobue G; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Nakashima K; Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.
J Neurol Sci ; 367: 51-5, 2016 Aug 15.
Article em En | MEDLINE | ID: mdl-27423564
ABSTRACT
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share common clinical, genetic and neuropathological features. Some ALS patients have behavioral/personality changes, which could result in significant obstacles in the care provided by family members and caregivers. An easy screening tool would contribute greatly to the evaluation of these symptoms. We translated the ALS-FTD-Questionnaire, developed in the Netherlands, into Japanese (ALS-FTD-Q-J) and examined the clinimetric properties (internal consistency, construct and clinical validity). Patients with ALS and/or behavioral variant FTD (bvFTD) were evaluated alongside healthy controls in this multicenter study. All ALS patients, regardless of bvFTD status, were further evaluated by the frontal behavioral inventory (FBI) and for frontal/executive function, cognition, anxiety/depression, and motor functions. Data from 146 subjects were analyzed ALS (92), ALS-bvFTD (6), bvFTD (16), and healthy controls (32). The internal consistency of the ALS-FTD-Q-J was good (Cronbach α=0.92). The ALS-FTD-Q-J showed construct validity as it exhibited a high correlation with the FBI (r=0.79). However, correlations were moderate with anxiety/depression and low with cognitive scales, in contrast to the original report, i.e. a moderate correlation with cognition and a low correlation with anxiety/depression. The ALS-FTD-Q-J discriminated ALS patients from (ALS-)bvFTD patients and controls. Thus, the ALS-FTD-Q-J is useful for evaluating Japanese ALS/FTD patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inquéritos e Questionários / Demência Frontotemporal / Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Neurol Sci Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inquéritos e Questionários / Demência Frontotemporal / Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Neurol Sci Ano de publicação: 2016 Tipo de documento: Article